Stream every public session from the 27th annual Global Conference right here on our website.

Watch Here
results for:

Content Type

Centers and Programs

Topics

Tags

Refine by Date

150
Creating a Nonprofit Marketplace for Shelved Drugs: Lessons from a Pilot Project report
Creating a Nonprofit Marketplace for Shelved Drugs: Lessons from a Pilot Project
Many promising medicines, despite strong safety data and pharmaceutical characteristics, are discon
tinued by drug companies for nonscientific reasons, including strategic, organizational, and financial considerations.
Sep 14, 2021
Share the Data: Overcoming Trade-Offs in Tech Regulation report
Share the Data: Overcoming Trade-Offs in Tech Regulation
DOWNLOAD SUM
May 5, 2021
Hedging Pipeline Risk in Pharma: FDA Swaps and Annuities report
Hedging Pipeline Risk in Pharma: FDA Swaps and Annuities
The cost of capital to conduct medical R&D is high because investors must be compensated with s
ignificant returns to offset the risky and long drug-development process.
Jul 22, 2019
Advancing Models of Patient Engagement: Patient Organizations as Research and Data Partners report
Advancing Models of Patient Engagement: Patient Organizations as Research and Data Partners
FasterCures, alongside other patient-focused advocacy organizations, has long worked with stakehold
ers such as product developers and regulators to define and implement the “how to” of patient
Oct 19, 2020
Nonprofits: A Growing Force in Drug Development report
Nonprofits: A Growing Force in Drug Development
Shepherding a drug from discovery to the market is a complex process that involves many actors.
May 8, 2020
Leveraging Data-Driven Patient Participation to Accelerate Medical Research report
Leveraging Data-Driven Patient Participation to Accelerate Medical Research
The fuel for biomedical innovation is data.
May 14, 2020
Data Collection and Use During COVID-19 report
Data Collection and Use During COVID-19
The United States—as of June 2020—has more reported cases of COVID-19 than any other country in the
world, despite having many of the same resources as other countries that curbed the pandemic more successfully.
Jun 11, 2020
Cures for Life: Long-Term Follow-Up Data Collection for Cell and Gene Therapies report
Cures for Life: Long-Term Follow-Up Data Collection for Cell and Gene Therapies
Through significant advancements in biomedical innovation, new promising gene and cell therapy trea
tments may be the key to unlocking the cure to debilitating genetic, oncologic, and other diseases that were once deemed incurable.
Jul 10, 2020
Patient-Focused Drug Development Meetings: Smart Practices from Community Leaders report
Patient-Focused Drug Development Meetings: Smart Practices from Community Leaders
FasterCures, a center of the Milken Institute, designed this guide for patient advocacy organizatio
ns that are interested in hosting, or are currently planning, an externally led patient-focused drug development (PFDD)
Sep 3, 2020
GBM: Giving Smarter report
GBM: Giving Smarter
Glioblastoma Multiforme (GBM) is an aggressive malignant brain tumor involving glial cells of the b
rain. At the time of this report, nearly 15,000 people were diagnosed with GBM each year in the United States and Europe.
Sep 3, 2020
Comment Letter to the CFPB: Alternative Data and Modeling Techniques in the Credit Process report
Comment Letter to the CFPB: Alternative Data and Modeling Techniques in the Credit Process
The Milken Institute Center for Financial Markets provided a response to the Consumer Fin
ancial Protection Bureau (CFPB) upon request for comments regarding use
May 19, 2017
State Technology and Science Index 2016: Sustaining Americas Innovation Economy report
State Technology and Science Index 2016: Sustaining Americas Innovation Economy
As the Great Recession recedes in our rearview mirrors, it is becoming ever more apparent that inno
vative activities are determining an increasing proportion of the long-term economic growth of cities, metropolitan areas, regions, states, and even natio
Oct 23, 2016